Pages that link to "Q27975837"

The following pages link to Szabolcs Lehel (Q27975837):

Displaying 37 items.

• Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes (Q27115017) (← links)
• Serotonin 1B Receptor Binding Is Associated With Trait Anger and Level of Psychopathy in Violent Offenders (Q27230262) (← links)
• Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study (Q28239178) (← links)
• Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36. (Q33851479) (← links)
• Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers (Q34025072) (← links)
• Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study (Q36795478) (← links)
• Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study (Q39003215) (← links)
• Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin (Q39997514) (← links)
• Labeling and preliminary in vivo evaluation of the 5-HT(7) receptor selective agonist [(11)C]E-55888. (Q41096412) (← links)
• The role of PET scan among cardiologic imaging methods (Q44037576) (← links)
• [The [18F]-FNECA serves as a suitable radioligand for PET investigation of purinergic receptor expression]. (Q44037581) (← links)
• Development of a (11)C-labeled tetrazine for rapid tetrazine-trans-cyclooctene ligation (Q46912387) (← links)
• High brain serotonin levels in migraine between attacks: A 5-HT4 receptor binding PET study. (Q47827409) (← links)
• The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C]Cimbi-36 labeled in two positions (Q47928428) (← links)
• Convergent 18F-labeling and evaluation of N-benzyl-phenethylamines as 5-HT2A receptor PET ligands (Q48041213) (← links)
• Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands (Q48054775) (← links)
• Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study (Q48182063) (← links)
• Evaluation of 3-Ethyl-3-(phenylpiperazinylbutyl)oxindoles as PET Ligands for the Serotonin 5-HT₇ Receptor: Synthesis, Pharmacology, Radiolabeling, and in Vivo Brain Imaging in Pigs (Q48253988) (← links)
• Radiolabelling and PET brain imaging of the α₁-adrenoceptor antagonist Lu AE43936. (Q48287962) (← links)
• Radiosynthesis and Evaluation of [11C]3-Hydroxycyclopent-1-enecarboxylic Acid as Potential PET Ligand for the High-Affinity γ-Hydroxybutyric Acid Binding Sites (Q48344927) (← links)
• Development of a simple proton nuclear magnetic resonance-based procedure to estimate the approximate distribution coefficient at physiological pH (logD7.4): Evaluation and comparison to existing practices (Q48409938) (← links)
• Synthesis and evaluation of [¹¹C]Cimbi-806 as a potential PET ligand for 5-HT₇ receptor imaging (Q48478689) (← links)
• Brain serotonin 4 receptor binding is associated with the cortisol awakening response (Q48892729) (← links)
• 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements (Q48956848) (← links)
• Cerebral serotonin 4 receptors and amyloid-β in early Alzheimer's disease (Q51004415) (← links)
• Synthesis, radiolabeling and in vivo evaluation of [(11)C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT(7) receptor (Q51749237) (← links)
• Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT₇ receptor. (Q53010201) (← links)
• Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors. (Q53078055) (← links)
• [Synthesis of radiopharmaceuticals for PET investigations]. (Q53677467) (← links)
• Accelerating preclinical PET-screening: reductive amination with [11C]methoxybenzaldehydes (Q57396183) (← links)
• Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (Q61632262) (← links)
• HPLC methods for the purification of [11C]-labelled radiopharmaceuticals: reversal of the retention order of products and precursors (Q61634534) (← links)
• In vivo evaluation of a series of substituted 11C-phenetylamines as 5-HT2A agonist PET tracers (Q61634535) (← links)
• Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding (Q61651342) (← links)
• Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (Q63367316) (← links)
• Measuring endogenous changes in serotonergic neurotransmission with [C]Cimbi-36 positron emission tomography in humans (Q64057600) (← links)
• A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding (Q90131736) (← links)